Great question — and the science answers it directly.
Neuvéra's oral dissolving strips incorporate a proprietary blend of key absorption enzymes — including Beta Cyclodextrin and Sodium Caprate — that work in two ways: they temporarily expand the mucosal lining of the mouth to create a wider absorption pathway, and they encapsulate the peptide molecule during transit, escorting it through the mucosal barrier and directly into systemic circulation — bypassing first-pass digestion entirely.
The result is clinically validated 92.5% absorption with a 5–15 minute onset of action, on par with injectables.
To validate this across all peptide sizes, our clinical study was conducted using Glutathione — deliberately chosen because it has the largest molecular size of any peptide in our product line.
The logic was simple: if Neuvéra's delivery technology achieves 92.5% absorption with the biggest molecule, every other peptide we formulate will perform equal to or better than that benchmark. The study confirmed it.
So yes — the strips work. The enzymes solve the size problem. That's the entire point of Neuvéra's proprietary delivery technology.